...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Watch it before it gets moved to "Off Topic Forum" by the thought police here.

,,,very impressive video...I dont see how it is off-topic!,,even knowing its an advert of sorts...but when ZE is front row center it should be of interest to all shareholders..great find there 10-41,,,,

 

Share
New Message
Please login to post a reply